Evaluating hydronidone for the treatment of chronic hepatitis B-associated liver fibrosis
Source: News-Medical
Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis.
Background and aims
Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for the treatment of chronic hepat… [1088 chars]